Jeannine Brant, PhD, APRN, AOCN

home / authors / jeannine-brant-phd-aprn-aocn

Articles

Jeannine Brant on the Benefits of Patient-Reported Outcomes

Jeannine Brant on the Benefits of Patient-Reported Outcomes

Jeannine Brant, PhD, APRN, AOCN
April 29th 2016

Jeannine Brant, PhD, Billings Clinic, discusses the benefits of patient-reported outcomes in cancer care.

Jeannine Brant Discusses the Future of Palliative Care

Jeannine Brant Discusses the Future of Palliative Care

Jeannine Brant, PhD, APRN, AOCN
January 14th 2015

Jeannine Brant, PhD, APRN, AOCN, oncology clinical nurse specialist, nurse scientist, Billings Clinic, shares her thoughts on how palliative care will be integrated in the future.

Jeannine Brant on Integrating Palliative Care and the Nurse's Role

Jeannine Brant on Integrating Palliative Care and the Nurse's Role

Jeannine Brant, PhD, APRN, AOCN
October 24th 2014

Jeannine Brant, PhD, APRN, AOCN, oncology clinical nurse specialist, nurse scientist, Billings Clinic, discusses the best way to integrate palliative care and what role the nurse can play in palliative care.

Latest Updated Articles

ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Published: June 23rd 2024 | Updated: July 27th 2024
ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Close up of hand touching smartwatch with health app on the screen, gadget for fitness active lifestyle. © sitthiphong - stock.adobe.com
Published: April 11th 2024 | Updated: July 27th 2024
Navigating Wearable Technology in Oncology Nursing While Avoiding Data Fatigue
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Published: July 11th 2023 | Updated: July 27th 2024
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Case Study: Recognizing the Typical Signs of Bladder Cancer
Published: July 11th 2023 | Updated: July 27th 2024
Case Study: Recognizing the Typical Signs of Bladder Cancer
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
Published: June 14th 2024 | Updated: July 27th 2024
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
Published: April 28th 2024 | Updated: July 27th 2024
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
© 2024 MJH Life Sciences

All rights reserved.